alpha-aminopyridine has been researched along with Cholera Infantum in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golpe, R; Gómez-Rodríguez, M | 1 |
| Cersosimo, RJ | 1 |
| Calzetta, L; Cazzola, M; Matera, MG; Rogliani, P | 1 |
| Martínez, FJ | 1 |
| Klein, PD | 1 |
| LeJemtel, T; Mancini, D; Sonnenblick, E | 1 |
| Treadway, G | 1 |
4 review(s) available for alpha-aminopyridine and Cholera Infantum
| Article | Year |
|---|---|
Cyclin-dependent kinase 4/6 inhibitors for the management of advanced or metastatic breast cancer in women.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Diseases; Humans; Molecular Targeted Therapy; Neoplasm Staging; Neutropenia; Piperazines; Progression-Free Survival; Protein Kinase Inhibitors; Purines; Pyridines; Randomized Controlled Trials as Topic | 2019 |
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis.
Topics: Aminopyridines; Benzamides; Cyclopropanes; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Medication Adherence; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
[Roflumilast: clinical review of a new option for the treatment of inflammation in COPD].
Topics: Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Inflammation; Multicenter Studies as Topic; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Weight Loss | 2010 |
Intravenous use of amrinone for the treatment of the failing heart.
Topics: Aminopyridines; Amrinone; Cardiac Complexes, Premature; Cardiac Output; Cardiotonic Agents; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Diseases; Heart Failure; Humans; Injections, Intravenous; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Thrombocytopenia; Vasodilator Agents | 1985 |
1 trial(s) available for alpha-aminopyridine and Cholera Infantum
| Article | Year |
|---|---|
Clinical safety of intravenous amrinone--a review.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug Interactions; Gastrointestinal Diseases; Heart Failure; Humans; Hypotension; Thrombocytopenia | 1985 |
2 other study(ies) available for alpha-aminopyridine and Cholera Infantum
| Article | Year |
|---|---|
Intolerance to roflumilast in real-life clinical practice.
Topics: Aged; Aged, 80 and over; Aminopyridines; Benzamides; Cyclopropanes; Female; Gastrointestinal Diseases; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2017 |
Clinical applications of 13CO2 measurements.
Topics: Acetamides; Amino Acids; Aminopyridines; Animals; Breath Tests; Carbon Dioxide; Carbon Isotopes; Digestive System Physiological Phenomena; Gastrointestinal Diseases; Humans; Lipid Metabolism; Liver; Liver Cirrhosis; Mass Spectrometry; Rats; Triolein | 1982 |